Phuong N. Huynh

Array ( [id] => 6062158 [patent_doc_number] => 20110200593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Combination Therapy for the Treatment of Ocular Neovascular Disorders' [patent_app_type] => utility [patent_app_number] => 12/987508 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 31631 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200593.pdf [firstpage_image] =>[orig_patent_app_number] => 12987508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7723982 [patent_doc_number] => 08097252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Methods and compositions for administering therapeutic and diagnostic agents' [patent_app_type] => utility [patent_app_number] => 12/985775 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34571 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097252.pdf [firstpage_image] =>[orig_patent_app_number] => 12985775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038430 [patent_doc_number] => 20110091479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/973480 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13804 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091479.pdf [firstpage_image] =>[orig_patent_app_number] => 12973480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239863 [patent_doc_number] => 20120148585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'FUSION MOLECULES AND METHODS FOR TREATMENT OF IMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/971888 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33514 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12971888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10881999 [patent_doc_number] => 08906377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Stably tethered structures of defined compositions with multiple functions or binding specificities' [patent_app_type] => utility [patent_app_number] => 12/968936 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 45834 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12968936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8820912 [patent_doc_number] => 20130121958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'STREPTAVIDIN AND BIOTIN-BASED ANTIGEN DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/517429 [patent_app_country] => US [patent_app_date] => 2010-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 33173 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932218 [patent_doc_number] => 08491914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Dock-and-lock (DNL) complexes for delivery of interference RNA' [patent_app_type] => utility [patent_app_number] => 12/964021 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24109 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12964021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118560 [patent_doc_number] => 20110076233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting' [patent_app_type] => utility [patent_app_number] => 12/964132 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27936 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076233.pdf [firstpage_image] =>[orig_patent_app_number] => 12964132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464662 [patent_doc_number] => 20120269830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'CONJUGATES WITH IMPROVED PHARMACOKINETIC PROPERTIES' [patent_app_type] => utility [patent_app_number] => 13/514019 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21116 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502207 [patent_doc_number] => 20110263820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'ANTIBODIES AND PROCESSES FOR PREPARING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/962197 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 49490 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263820.pdf [firstpage_image] =>[orig_patent_app_number] => 12962197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110222 [patent_doc_number] => 20110189170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Chimeric Anti-VEGF-D Antibodies and Humanized Anti-VEGF-D Antibodies and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 12/960205 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26552 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189170.pdf [firstpage_image] =>[orig_patent_app_number] => 12960205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151935 [patent_doc_number] => 08168409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Compositions and methods relating to anti-IGF-1 receptor antibodies' [patent_app_type] => utility [patent_app_number] => 12/954518 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 43 [patent_no_of_words] => 46810 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168409.pdf [firstpage_image] =>[orig_patent_app_number] => 12954518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464666 [patent_doc_number] => 20120269834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'IMMUNOGLOBULIN CLEAVAGE FRAGMENT VACCINE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/318168 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15648 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8269940 [patent_doc_number] => 08211440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Multivalent immunoglobulin-based bioactive assemblies' [patent_app_type] => utility [patent_app_number] => 12/949536 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 37 [patent_no_of_words] => 50290 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12949536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585672 [patent_doc_number] => 20130004493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'EPITHELIAL MEMBRANE PROTEIN-2 (EMP2) AND PROLIFERATIVE VITRORETINOPATHY (PVR)' [patent_app_type] => utility [patent_app_number] => 13/510877 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27940 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080159 [patent_doc_number] => 20110142859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/939533 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 89261 [patent_no_of_claims] => 238 [patent_no_of_ind_claims] => 215 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142859.pdf [firstpage_image] =>[orig_patent_app_number] => 12939533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724166 [patent_doc_number] => 08097436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/938180 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 48321 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097436.pdf [firstpage_image] =>[orig_patent_app_number] => 12938180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984524 [patent_doc_number] => 20110097322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'PARTIALLY LOADED ANTIBODIES AND METHODS OF THEIR CONJUGATION' [patent_app_type] => utility [patent_app_number] => 12/916294 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28349 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097322.pdf [firstpage_image] =>[orig_patent_app_number] => 12916294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484611 [patent_doc_number] => 20110250234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/913271 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11821 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250234.pdf [firstpage_image] =>[orig_patent_app_number] => 12913271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346748 [patent_doc_number] => 20120207673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Modified Variable Domain Molecules And Methods For Producing And Using Same' [patent_app_type] => utility [patent_app_number] => 13/502674 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 38628 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502674 [rel_patent_id] =>[rel_patent_doc_number] =>)